Aagami team are happy to anounced that their Louisiana based Biotechnology client have given another assignment (3rd from them)  to support their cross border partnering. This time the mandate is for global and not restricted to any geography. In previous assignment, Aagami got a US$ 10 Million deal for the same client.

The client company specializes in innovative cancer treatment and their mission is to improve the overall patient condition through innovative bioimmunotherapy with proven treatment protocols, to lower deaths associated with cancer and reduce the cost of cancer treatment.

With a dedicated team in India, Aagami looks forward to put its best foot forward in bringing yet another success to its client who has known and appreciated Aagami work for a long time now.